Abstract
Pseudomonas aeruginosa is identified as a versatile opportunistic microorganism with metabolic diversity contributing to a wide range of health burdens, especially in immunocompromised patients. This bacterium is the cause of 10 to 20% of nosocomial infections. In this study, we evaluated the phenotypic characterizations of biofilm formation in P. aeruginosa clinical isolates using micro-titer plate assay. Indeed, we estimated the prevalence of QS (rhlI, rhlR, rhlAB, lasB, lasI, lasR, aprA) and virulence genes (pslA and cupA) by PCR. The results showed that among 69% of the isolates forming biofilm, 9% were strong biofilm producers, whereas 13% and 47% of isolates produced moderate and low amounts of biofilm, respectively. All isolates possessed cupA and seven QS genes (rhlI, rhlR, rhlAB, lasB, lasI, lasR, aprA), while 92% of the isolates possessed the pslA gene. Identification of these genes and their association with biofilm formation can be advantageous in adopting therapeutic methods.
Key Words: Pseudomonas aeruginosa, Biofilm, Quorum sensing, Fimbrial, cupA, pslA
INTRODUCTION
Pseudomonas aeruginosa is a rod-shaped, gram-negative, opportunistic versatile pathogen bacterium [1] leading to acute as well chronic infections in intensive care unit (ICU), immunocompromised, and cystic fibrosis patients [2,3]. Up to 10-20% of nosocomial infections are notably associated with P. aeruginosa pathogenesis. The World Health Organization (WHO) has classified this organism as the first antibiotic-resistance human pathogen making it necessary to develop novel antibacterial agents [4-7].
Microbial communities are known as biofilms commonly exist in environmental and clinical settings [8]. They cause antibiotic resistance and help bacteria to evade the host immune system [9,10]. In this regard, P. aeruginosa can produce biofilm in the respiratory tract or pulmonary tissue of cystic fibrosis patients (CF) and on abiotic surfaces such as contact lenses and catheters [11,12]. Exopolysaccharides (EPSs) are a major constituent of microbial biofilms [13]. At least three EPSs including alginate, Pel, and Psl have been identified as associated with biofilm formation in P. aeruginosa [15]. In this context, Ma et al., (2006) demonstrated that Psl polysaccharide plays a significant role in the attachment of P. aeruginosa colony-biofilms to both abiotic and biotic surfaces at the primary phases. It as well improves the maintenance of biofilm structure after adherence. It is also counted as that Psl serves as a scaffold for other biofilm components preserving the natural structure of biofilm [14].
The cupA gene cluster, another key player in the pathogenesis of P. aeruginosa, is more responsible for biofilm development during the early stages compared to type IV pili [16]. The expression of many virulence genes, including biofilm-associated factors in P. aeruginosa is regulated by Quorum sensing (QS) network [17]. QS is a complicated microbial cell-cell mechanism entailing in the production and maintenance of biofilm. Two QS systems, the las and rhl systems have been identified in P. aeruginosa so far. In this context, the LasI system controls the formation of the homoserine lactone (3-oxo-C12) signal molecule which plays a key role in forming biofilms [17,18]. It reacts with the LasR activator and in addition to positive feedback on itself, triggers several other virulence genes including lasB, lasA, aprA, and toxA [19].
This study aimed to evaluate the phenotypic biofilm formation and prevalence of aforementioned QS and virulence genes in the isolates cultured from clinical cases of P. aeruginosa infection.
MATERIALS AND METHODS
Bacterial strain: The bacteria used in this study were isolated from various clinical specimens (urine, skin, sputum, body fluid, blood, wound, central vein blood). They included PAO1, and 100 strains of P. aeuginosa stored in a bacterial collection of the School of Veterinary Medicine, Shiraz University.
Biofilm assay: The biofilm was developed on a 96-well polystyrene micro-titre plate according to Christensen et al., with some changes [20]. Concisely, biofilm bacteria were grown in trypticase soy broth (TSB) medium (MERK Germany) enriched with 1% glucose (BDH England). After incubation at 37°C for 24 hours, the bacterial suspensions were diluted 1/100 with sterile fresh TSB containing 1% glucose. A 200 µl of diluted microbial suspension was poured into the 96-well polystyrene Plates (SPL Korea) in triplicate. Negative controls only consisting sterile TSB medium. Three wells were used for each sample. Afterward, the plates were covered and incubated at 37°C for 24 hours. Subsequently, the solution content of the wells was aspirated and the wells were washed three times by addition 200 µl sterile phosphate-buffered saline (PBS). The formed biofilms were fixed with absolute methanol (Merck Germany). After 15 minutes the plates were rinsed off with PBS and air-dried. The wells were stained with 200 µl of 1% crystal violet solution (Merck Germany). Excess stain was removed using sterile distilled water. Finally, stained biofilms dissolved in 33% (v/v) glacial acetic acid (Merck Germany). The OD value (ODw) of each well was provided at 570 nm using an ELISA reader (Biotek USA). All strains were categorized as represented by Stepanovic et al. [21]. The cut-off OD value (ODc) for each sample was described as three standard deviations above the mean OD of the negative control. The strains were introduced into four following groups according to the ODw: non-biofilm formation (0) (ODw ≤ ODc); weakly biofilm formation (+) (ODc<ODw≤2xODc); moderately biofilm formation (++) (2xODc < ODw ≤ 4xODc); and strongly biofilm formation (+++) (4xODc < ODw).
PCR for detection of biofilm-related and QS genes: The bacterial isolates were evaluated for seven genes including Qs genes (rhlI, rhlR, rhlAB, lasB, lasI, lasR, aprA) and two other genes (cupA, pslA) contributing to biofilm formation by PCR. Nine primer pairs were used for polymerization, as previously described (Table 1) [19,22,23]. DNA extraction was performed using the boiling method. The PCR reaction mixture contained10 µl Master mix (1.5 X AMPLICON DENMARK), 0.5 µl of 10 pmol forward and reverse primers concentration, 2.5 µl DNA, and 6.5 µl of nuclease-free water. PCR programs for the detection of different genes are described in Table 2.
Table 1.
Primers used for detection of the Quorum-Sensing and virulence genes
| Genes | Sequence of primers | Amplicon Size (bp) | References |
|---|---|---|---|
| rhlI | 5′-TTC ATC CTC CTT TAG TTC TTC C 3′ 5′-TTC CAG CGA TTC AGA GAG C-3′ |
155 | |
| rhlR | 5′-TGC ATT TTA TCG ATC AGG GC-3′ 5′-CAC TTC CTT TTC CAG GAC G-3′ |
133 | |
| rhlAB | 5′-TCA TGG AAT TGT CAC AAC CGC-3′ 5′- ATA CGG CAA AAT CAT GGC AAA C-3′ |
151 | |
| lasB | 5′-TTC TAC CCG AAG GAC TGA TAC-3′ 5′-AAC ACC CAT GAT CGC AAC-3′ |
153 | |
| lasI | 5′-CGT GCT CAA GTG TTC AAG-3′ 5′-TAC AGT CGG AAA AGC CCA G-3′ |
295 | |
| lasR | 5′-AAG TGG AAA ATT GGA GTG GAG-3′ 5′-GTA GTT GCC GAC GAC GAT GAA G-3′ |
130 | |
| aprA | 5′-ACC CTG TCC TAT TCG TTC C-3′ 5′-GAT TGC AGC GAC AAC TTG G-3′ |
140 | |
| cupA | 5′-CTA CCG CTA TTC CAC CGA AG-3′ 5′-AGG AGC CGG AAA GAT AGA GG-3′ |
172 | |
| pslA | 5′-CAC TGG ACG TCT ACT CCG ACG ATA T-3′ 5′-GTT TCT TGA TCT TGT GCA GGG TGT C-3′ |
1119 |
Table 2.
PCR programs for detection of different genes
| Genes/Steps | QS | cupA | pslA |
|---|---|---|---|
| Initial denaturation | 94°C/ 5min | 94°C/ 5min | 95°C/ 5min |
| Denaturation | 94°C/ 1min | 95°C/ 40 sec | 94°C/ 30 sec |
| Annealing | 56°C/ 1min | 59°C/ 45 sec | 55°C/ 30 sec |
| Extension | 72°C/ 1 min | 72°C/ 1 min | 72°C/ 1 min |
| Final extension | 72°C/ 8min | 72°C/ 7 min | 72°C/ 10 min |
| Cycle | 32 | 40 | 30 |
RESULTS AND DISCUSSION
In the present investigation, 100 clinical samples of P. aeruginosa were assessed for biofilm formation and the presence of QS, fimbrial cupA and pslA genes. In total, 69% of the isolates formed biofilm of which 9% shaped strong biofilm; 13% generated moderate biofilm and 47% formed weak biofilm. All of the isolates (100%) possessed seven QS genes (rhlI, rhlR, rhlAB, lasB, lasI, lasR, aprA) and cupA gene, while 92% (92/100) of the isolates possessed pslA gene (Fig. 1 and 2).
Figure 1.
Agaros gel electrophoresis, Lane 1. pslA gene (1119bp), Lane 2. lasB, lasI, and lasR genes (153, 295 and 130bp), Lane 3. 50bp DNA ladder, Lane 4. rhlI and rhlR genes (133 and 155bp), Lane 5. Negetive control, Lanes 6 and 8 cupA gene (172bp).
Figure 2.

Agaros gel electrophoresis, Lane 1. 100bp DNA ladder, Lane 2. Negative control, Lanes 3 and 4. aprA and rhlB genes (140 and 151bp).
The quantitative micro-titer plate assay, which is an efficacious method for biofilm detection has been used. Similar to our results, Pereze et al., [24] reported that 68% of the isolates formed biofilm. In other studies by Ghadaksaz et al., [25], and Lima et al. [26] 50.9 and 58.1% of isolates formed biofilm, respectively. Heidari and Eftekhar [27] showed that 43% of the isolates formed biofilm, of which 66.7% were strong and 33.3% were weak producers. The results of these studies were lower than our research. In contrast, Banar et al. [28], showed that more than 96% of isolates causing burn wound infection produced biofilm, of which 30.9% formed strong biofilm, 47.3% formed moderate biofilm and 21.8% formed weak biofilm. Likewise, in another research, Kamali et al. [29], indicated that among 83.75% of the isolates formed biofilm, 16.25% produced strong biofilm; 33.75% produced moderate biofilm; and 33.75% produced weak biofilm, while 16.25% of isolates did not produce any biofilm. Lima et al., [30], indicated that while 25% of isolates were non-adherent, 40% of them were weakly adherent, 25% were moderately adherent, and 10% were firmly adherent. Furthermore, in another study conducted by Lima et al., [31], among 77.5% of isolates produced biofilm, 42.5% were weakly adherent, 27.5% were moderately adherent and 7.5% were firmly adherent. Collectively, in most of these studies, the number of isolates forming weak biofilm was higher than other isolates, confirming our findings.
Biofilm formation is induced and regulated by numerous genes and environmental factors [32]. QS controls about 10% of genes in P. aeruginosa [33]. Therefore, the QS system is a potential target for developing novel therapies against P. aeruginosa infection. In this study, the genotypic analysis showed that all the isolates had seven QS genes mentioned earlier. Lima et al. [26] showed that four genes including lasI, lasR, rhlI, and rhlR were present in the isolates. Additionally, in another study by Lima et al., [31], 100 % of strains were positive for the lasR, rhlI and rhlR genes, and 97.5 % of them were positive for the lasI gene. Perez et al., [34], indicated that 90.1 % of isolates possessed lasI, lasR, rhlI, and rhlR genes. Moreover, Kadhim and Ali [35], reported that 81.6% of the isolates contained QS genes, among which the frequency of lasR, lasI, rhlR, and rhlI genes were 5, 78.3, 65, and 43.3%, respectively.
In the present study, the genes needed for biofilm organization were found in all isolates. However, 31% of the samples were not able to develop biofilms. This may be the result of some point mutations that occurred in the QS genes [36,37]. Another possibility is that the presence of several strains of P. aeruginosa at the site of the infection may lead to defective expression of QS genes [37].
All the studied isolates possessed the cupA gene. Similarly, Shafiei et al. [22] analyzed four clinical isolates and two standard strains of P. aeruginosa and showed that the cupA was present in all of the isolates. Vallet et al., [16], showed that cupA gene cluster plays a significant role in biofilm formation. They also indicated that CupA-dependent adhesions are more essential during the early stages of biofilm formation than type IV pili.
In our study, pslA gene was identified in 92% of the isolates. In a study, Emami et al., [23], showed that none of the negative biofilm samples contained the pslA gene, while 42% of the biofilm-positive isolates had the pslA gene. Ma et al., [38], indicated that the Psl is a substantial biofilm component playing a critical role in the resistance of P. aeruginosa species.
In conclusion, this study illustrated that the majority of clinical isolates of P. aeruginosa produced weak biofilm in vitro. It was also shown that the QS genes and virulence genes (pslA and cupA) were prevalent among the isolates. Identification of these genes and their association with biofilm formation can be advantageous in adopting therapeutic methods against P. aeruginosa infections.
Conflict of Interest:
The authors declare no conflict of interest.
References
- 1.Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs. 2007;67:351–368. doi: 10.2165/00003495-200767030-00003. [DOI] [PubMed] [Google Scholar]
- 2.Murray TS, Egan M, Kazmierczak BI. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Curr Opin Pediatr. 2007;19:83–88. doi: 10.1097/MOP.0b013e3280123a5d. [DOI] [PubMed] [Google Scholar]
- 3.Bhat S, Fujitani S, Potoski BA, Capitano B, Linden PK, Shutt K, Paterson DL. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical β-lactam antibiotic therapy be improved? Int J Antimicrob Agents. 2007;30:458–462. doi: 10.1016/j.ijantimicag.2007.05.022. [DOI] [PubMed] [Google Scholar]
- 4.Fazeli H, Akbari R, Moghim S, Narimani T, Arabestani MR, Ghoddousi AR. Pseudomonas aeruginosa infections in patients, hospital means, and personnel’s specimens. J Res Med Sci. 2012;17:332–337. [PMC free article] [PubMed] [Google Scholar]
- 5.Soukarieh F, Williams P, Stocks MJ, Cámara M. Pseudomonas aeruginosa Quorum Sensing Systems as Drug Discovery Targets: Current Position and Future Perspectives. J Med Chem. 2018;61:10385–10402. doi: 10.1021/acs.jmedchem.8b00540. [DOI] [PubMed] [Google Scholar]
- 6.Gonzalez MR, Ducret V, Leoni S, Perron K. Pseudomonas aeruginosa zinc homeostasis: Key issues for an opportunistic pathogen. Biochim Biophys Acta Gene Regul Mech. 2019;1862:722–733. doi: 10.1016/j.bbagrm.2018.01.018. [DOI] [PubMed] [Google Scholar]
- 7.Azam MW, Khan AU. Updates on the pathogenicity status of Pseudomonas aeruginosa. Drug Discov Today. 2019;24:350–359. doi: 10.1016/j.drudis.2018.07.003. [DOI] [PubMed] [Google Scholar]
- 8.Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol. 1995;49:711–745. doi: 10.1146/annurev.mi.49.100195.003431. [DOI] [PubMed] [Google Scholar]
- 9.Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol. 2007;5:48–56. doi: 10.1038/nrmicro1557. [DOI] [PubMed] [Google Scholar]
- 10.Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O’Toole GA. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature. 2003;426:306–310. doi: 10.1038/nature02122. [DOI] [PubMed] [Google Scholar]
- 11.Lam J, Chan R, Lam K, Costerton JW. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun. 1980;28:546–556. doi: 10.1128/iai.28.2.546-556.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature. 2000;407:762–764. doi: 10.1038/35037627. [DOI] [PubMed] [Google Scholar]
- 13.Sutherland IW. The biofilm matrix – an immobilized but dynamic microbial environment. Trends Microbiol. 2001;9:222–227. doi: 10.1016/s0966-842x(01)02012-1. [DOI] [PubMed] [Google Scholar]
- 14.Ma L, Jackson KD, Landry RM, Parsek MR, Wozniak DJ. Analysis of Pseudomonas aeruginosa conditional psl variants reveals roles for the psl polysaccharide in adhesion and maintaining biofilm structure postattachment. J Bacteriol. 2006;188:8213–8221. doi: 10.1128/JB.01202-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ryder C, Byrd M, Wozniak DJ. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol. 2007;10:644–648. doi: 10.1016/j.mib.2007.09.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Vallet I, Olson JW, Lory S, Lazdunski A, Filloux A. The chaperone/usher pathways of Pseudomonas aeruginosa: Identification of fimbrial gene clusters (cup) and their involvement in biofilm formation. Proc Natl Acad Sci U S A. 2001;98:6911–6916. doi: 10.1073/pnas.111551898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Teresa R, Iglewski BH. Bacterial quorum sensing in pathogenic relationships. Infect Immun . 2000;68:4839–4849. doi: 10.1128/iai.68.9.4839-4849.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Fuqua WC, Winans SC, Greenberg EP. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulatorst. J Bacteriol. 1994;176:269–275. doi: 10.1128/jb.176.2.269-275.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Zhu H, Bandara R, Conibear TCR, Thuruthyil SJ, Rice SA, Kjelleberg S, Givskov M, Willcox MDP. Pseudomonas aeruginosa with LasI quorum-sensing deficiency during corneal infection. Investig Ophthalmol Vis Sci. 2004;45:1897–1903. doi: 10.1167/iovs.03-0980. [DOI] [PubMed] [Google Scholar]
- 20.Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: A quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985;22:996–1006. doi: 10.1128/jcm.22.6.996-1006.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Stepanović S, Vuković D, Dakić I, Savić B, Švabić-Vlahović M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40:175–179. doi: 10.1016/s0167-7012(00)00122-6. [DOI] [PubMed] [Google Scholar]
- 22.Shafiei M, Ali AA, Shahcheraghi F, Saboora A, Noghabi KA. Eradication of Pseudomonas aeruginosa biofilms using the combination of n-butanolic Cyclamen coum extract and ciprofloxacin. Jundishapur J Microbiol. 2014;7:e14358. doi: 10.5812/jjm.14358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Emami S, Nikokar I, Ghasemi Y, Ebrahimpour M, Ebrahim-Saraie HS, Araghian A, Faezi S, Farahbakhsh M, Rajabi A. Antibiotic resistance pattern and distribution of pslA gene among biofilm producing Pseudomonas aeruginosa isolated from waste water of a burn center. Jundishapur J Microbiol. 2015;8:e23669. doi: 10.5812/jjm.23669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Perez LRR, Costa MCN, Freitas ALP, Barth AL. Evaluation of biofilm production by Pseudomonas aeruginosa isolates recovered fromcystic fibrosis and non-cystic fibrosis patients. Braz J Microbiol. 2011;42:476–479. doi: 10.1590/S1517-838220110002000011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ghadaksaz A, Imani Fooladi AA, Hosseini HM, Amin M. The prevalence of some Pseudomonas virulence genes related to biofilm formation and alginate production among clinical isolates. J Appl Biomed. 2015;13:61–68. [Google Scholar]
- 26.Rodrigues RL, Lima JL da C, de Sena KX da FR, Maciel MAV. Phenotypic and genotypic analysis of biofilm production by Pseudomonas aeruginosa isolates from infection and colonization samples. Rev Soc Bras Med Trop. 2020;53:e20200399. doi: 10.1590/0037-8682-0399-2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Samira H, Fereshteh E. Biofilm formation and β-lactamase production in burn isolates of Pseudomonas aeruginosa. Jundishapur J Microbiol. 2015;8:e15514. doi: 10.5812/jjm.15514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Banar M, Emaneini M, Satarzadeh M, Abdellahi N, Beigverdi R, Van Leeuwen WB, Jabalameli F. Evaluation of mannosidase and trypsin enzymes effects on biofilm production of Pseudomonas aeruginosa isolated from burn wound infections. PLoS One. 2016;11:e0164622. doi: 10.1371/journal.pone.0164622. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kamali E, Jamali A, Ardebili A, Ezadi F, Mohebbi A. Evaluation of antimicrobial resistance, biofilm forming potential, and the presence of biofilm-related genes among clinical isolates of Pseudomonas aeruginosa. BMC Res Notes. 2020;13:4–9. doi: 10.1186/s13104-020-4890-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Da Costa Lima JL, Alves LR, Da Paz JNP, Rabelo MA, Maciel MAV, De Morais MMC. Analysis of biofilm production by clinical isolates of Pseudomonas aeruginosa from patients with ventilator-Associated pneumonia. Rev Bras Ter Intensiva. 2017;29:310–316. doi: 10.5935/0103-507X.20170039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Lima JL da C, Alves LR, Jacomé PRL de A, Bezerra Neto JP, Maciel MAV, Morais MMC de. Biofilm production by clinical isolates of Pseudomonas aeruginosa and structural changes in LasR protein of isolates non biofilm-producing. Braz J Infect Dis. 2018;22:129–136. doi: 10.1016/j.bjid.2018.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Fazli M, Almblad H, Rybtke ML, Givskov M, Eberl L, Tolker-Nielsen T. Regulation of biofilm formation in Pseudomonas and Burkholderia species. Environ Microbiol. 2014;16:1961–1981. doi: 10.1111/1462-2920.12448. [DOI] [PubMed] [Google Scholar]
- 33.Wagner VE, Bushnell D, Passador L, Brooks AI, Iglewski BH. Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: Effects of growth phase and environment. J Bacteriol. 2003;185:2080–2095. doi: 10.1128/JB.185.7.2080-2095.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Perez LRR, Machado ABMP, Barth AL. The presence of quorum-sensing genes in pseudomonas isolates infecting cystic fibrosis and non-cystic fibrosis patients. Curr Microbiol. 2013;66:418–420. doi: 10.1007/s00284-012-0290-5. [DOI] [PubMed] [Google Scholar]
- 35.Kadhim D, Ali MR. Prevalence study of quorum sensing groups among clinical isolates of Pseudomonas aeruginosa. Int J Curr Microbiol App Sci. 2014;3:204–215. [Google Scholar]
- 36.Boşgelmez-Tinaz G, Ulusoy S. Characterization of N-butanoyl-l-homoserine lactone (C4-HSL) deficient clinical isolates of Pseudomonasaeruginosa. Microb Pathog. 2008;44:13–19. doi: 10.1016/j.micpath.2007.06.005. [DOI] [PubMed] [Google Scholar]
- 37.Senturk S, Ulusoy S, Bosgelmez-Tinaz G, Yagci A. Quorum sensing and virulence of pseudomonas aeruginosa during urinary tract infections. J Infect Dev Ctries. 2012;6:501–507. doi: 10.3855/jidc.2543. [DOI] [PubMed] [Google Scholar]
- 38.Ma L, Conover M, Lu H, Parsek MR, Bayles K, Wozniak DJ. Assembly and development of the Pseudomonasaeruginosa biofilm matrix. PLoS Pathog. 2009;5:e1000354. doi: 10.1371/journal.ppat.1000354. [DOI] [PMC free article] [PubMed] [Google Scholar]

